← Product Code [HJK](/submissions/OP/subpart-b%E2%80%94diagnostic-devices/HJK) · K022413 # LUNEAU 3 MIRROR LENS (K022413) _Luneau SA · HJK · Sep 24, 2002 · Ophthalmic · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/OP/subpart-b%E2%80%94diagnostic-devices/HJK/K022413 ## Device Facts - **Applicant:** Luneau SA - **Product Code:** [HJK](/submissions/OP/subpart-b%E2%80%94diagnostic-devices/HJK.md) - **Decision Date:** Sep 24, 2002 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 886.1385 - **Device Class:** Class 2 - **Review Panel:** Ophthalmic ## Indications for Use The 3-Mirror Lens is an ophthalmic device used for the examination of the ocular fundus. ## Device Story Luneau 3-Mirror Lens is a handheld optical diagnostic device used by ophthalmologists during slit-lamp examinations. Device features mirrors to reflect images of the posterior chamber and retina of the patient's eye. Ophthalmologist holds lens against patient's eye while viewing through slit-lamp. Provides visualization of ocular fundus for diagnostic purposes. ## Clinical Evidence No clinical data provided; bench testing only. ## Technological Characteristics Optical diagnostic contact lens; constructed of Polymethylmethacrylate (PMMA); utilizes internal mirrors for light reflection to visualize the posterior chamber and retina; handheld form factor; non-powered; non-electronic; non-sterile/reusable. ## Regulatory Identification A polymethylmethacrylate (PMMA) diagnostic contact lens is a device that is a curved shell of PMMA intended to be applied for a short period of time directly on the globe or cornea of the eye for diagnosis or therapy of intraocular abnormalities. ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the edge. Inside the circle is a stylized image of three human profiles facing right, stacked on top of each other, with flowing lines representing hair or clothing. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 SEP 2 4 2002 Luneau S.A., c/o Jean Noel Young B.P. 252 28005 Chartres Cedex France Re: K022413 Trade/Device Name: Luneau 3-Mirror Lens Regulation Number: 21 CFR 886.1385 Regulation Name: Polymethylmethacrylate (PMMA) diagnostic contact lens Regulatory Class: Class II Product Code: HJK Dated: July 11, 2002 Received: July 24, 2002 Dear Mr. Young: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {1}------------------------------------------------ ## Page 2 - Jean Noel Young This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97), Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address . http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours, A. Ralph Rosenthal A. Ralph Rosenthal, M.D. Director Division of Ophthalmic and Ear. Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health {2}------------------------------------------------ Page 1 of 1. ## 510(k) Number (if known): K022413 Device Name: LUNEAU 3-MIRROR LENS ## Indications For Use: The 3-Mirror Lens is an ophthalmic device used for the examination of the ocular fundus. Description of the device: The 3-Mirror Lens is an optical device, which by the intermidiary of the mirrors, allows the ophthalmologist to observe different parts of the posterior chamber of the eye, in particular, the retina. The ophthalmologist holds the 3-Mirror Lens with his hand on the eye of the patient and he observes the images from the mirrors with a slit-lamp. (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use X Daniel W.R. Brown, Ph.D. (Division Sign Off) (Division Sign-Off) Division of Ophthalmic Ear, Nose and Throat Devises (Optional Format 3-10-98) 510(k) Number ________________________________________________________________________________________________________________________________________________________________ --- **Source:** [https://fda.innolitics.com/submissions/OP/subpart-b%E2%80%94diagnostic-devices/HJK/K022413](https://fda.innolitics.com/submissions/OP/subpart-b%E2%80%94diagnostic-devices/HJK/K022413) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com